Uncategorized
ADA: Lilly sets ‘new record in Weight Loss Olympics’ with next-gen asset
Over two years of treatment, Eli Lilly’s triple-G drug cut body weight by more than 30% in certain patients with obesity, cementing the pharma’s position as the frontrunner in the metabolic space.